Lipocine
LPCN
LPCN
31 hedge funds and large institutions have $6.63M invested in Lipocine in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more call options, than puts
Call options by funds: $66K | Put options by funds: $57K
0.13% more ownership
Funds ownership: 0.58% → 0.71% (+0.13%)
Holders
31
Holding in Top 10
–
Calls
$66K
Puts
$57K
Top Buyers
| 1 | +$474K | |
| 2 | +$472K | |
| 3 | +$317K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$168K |
| 5 |
SIM
Spark Investment Management
New York
|
+$118K |
Top Sellers
| 1 | -$310K | |
| 2 | -$39K | |
| 3 | -$12.9K | |
| 4 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$7.08K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.19K |